KAM
SCMP
Krensavage Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-1,304,376
| Closed | -$23.4M | – | 17 |
|
2017
Q4 | $23.4M | Sell |
1,304,376
-1,529,040
| -54% | -$27.4M | 7.3% | 5 |
|
2017
Q3 | $33.4M | Buy |
2,833,416
+13,708
| +0.5% | +$162K | 10.42% | 5 |
|
2017
Q2 | $29.6M | Buy |
2,819,708
+16,570
| +0.6% | +$174K | 8.99% | 5 |
|
2017
Q1 | $30.8M | Buy |
2,803,138
+939,383
| +50% | +$10.3M | 9.94% | 5 |
|
2016
Q4 | $25.3M | Buy |
1,863,755
+211,857
| +13% | +$2.87M | 9.05% | 4 |
|
2016
Q3 | $20.3M | Buy |
1,651,898
+20,500
| +1% | +$252K | 7.35% | 6 |
|
2016
Q2 | $17.9M | Buy |
1,631,398
+1,073,169
| +192% | +$11.8M | 6.45% | 8 |
|
2016
Q1 | $6.1M | Buy |
558,229
+2,577
| +0.5% | +$28.2K | 2.19% | 17 |
|
2015
Q4 | $9.61M | Buy |
555,652
+27,477
| +5% | +$475K | 3.07% | 13 |
|
2015
Q3 | $10.5M | Sell |
528,175
-439,229
| -45% | -$8.73M | 3.8% | 13 |
|
2015
Q2 | $15.9M | Buy |
967,404
+33,538
| +4% | +$551K | 5.99% | 7 |
|
2015
Q1 | $14.5M | Sell |
933,866
-24,182
| -3% | -$376K | 6.62% | 6 |
|
2014
Q4 | $13.7M | Buy |
+958,048
| New | +$13.7M | 7.62% | 3 |
|